Results 251 to 260 of about 3,456,235 (361)

Evaluation of Platelet Lysate-Based Medium and Protein Substrate for HUVEC Culture and Expansion. [PDF]

Biomedicines
Duarte Rojas JM, Restrepo Múnera LM, Estrada Mira S.   +2 more
europepmc   +1 more source

Thymus Dependent Mesothelial Proliferation after Antigenic Stimulation [PDF]

, 1969
W. F. Krüsmann, H. Kasemir, Hans Fischer   +2 more
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

27-Hydroxycholesterol in cancer development and drug resistance. [PDF]

J Enzyme Inhib Med Chem
Hou Y, Fu Z, Wang C, Kucharzewska P, Guo Y, Zhang S.   +5 more
europepmc   +1 more source

Facilitation of Tolerance in Weanling Mice by Enhancing the Proliferation of Donor Lymphoreticular Cells [PDF]

, 1964
Joshua E. Miller, Carlos Alberto Martínez, Robert A. Good   +2 more
openalex   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

The role and diagnostic value of deregulated miRNAs in cervical cancer. [PDF]

Discov Oncol
Parvizi M, Vaezi M, Jeddi F, Bakhshandeh M, Eghdam-Zamiri R, Mobaraki-Asl N, Esmati E, Karimi A.   +7 more
europepmc   +1 more source

Experimentally Induced Proliferation of the Rudimentary Gonad of an Intact Domestic Fowl [PDF]

, 1960
Walter Kornfeld
openalex   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

OVOL1 Promotes Proliferation and Metastasis of Non-Small Cell Lung Cancer by Regulating APOE-Mediated Cholesterol Metabolism. [PDF]

J Cell Mol Med
Feng S, Zhang L, Sun T, Xu L, Quan X, Zhao G, Zhang H.   +6 more
europepmc   +1 more source